Gynecologic cancer
Conditions
Interventions
Injection method Chemotherapy cycle 1 When febrile neutropenia [fever (axillary temperature with less than neutrophil count 1,000/mm3 more than 38 degrees Celsius)] develops at chemotherapy enforcem
Sponsors
Oita University Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Enforcement planned Patient Performance status(PS)is the patient with hematopoiesis, liver, the renal function to meet criteria of Patient following with 0-1 by the pharmacotherapy in the anticancer drug Neutrophile count>1,500/mm3 Platelet>100,000/mm3 1.5 times of 1.5 times serum creatinine <institution reference value upper limit of 2.5 times total bilirubin<institution reference value upper limit of GOT and GPT <institution reference value upper limit
Exclusion criteria
Exclusion criteria: 1) The patients with the bone marrow infiltration 2) Is the patients with hypersensitivity to Patient 3) G-CSF preparation which received radiotherapy within four weeks before registration at chemotherapy initiation 4) The patients who judged that a chief physician was inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neutropenic (neutrophil count <1,000/mm3) period in each treatment cycle | — |
Countries
Japan
Contacts
Public ContactYuhki Sato
Oita University Hospitaly Clinical Pharmacy
Outcome results
None listed